Diagnostic Significance of Paraneoplastic Neurological Syndromes
Author:
- Keiko TanakaKTKeiko Tanaka
- 1 January 2008
- journal article
- Published by Japanese Society of Internal Medicine in Nihon Naika Gakkai Zasshi
- Vol. 97 (8) , 1761-1763
Abstract
No abstract availableThis publication has 8 references indexed in Scilit:
- Anti-glial nuclear antibody: Marker of lung cancer-related paraneoplastic neurological syndromesJournal of Neuroimmunology, 2005
- Paraneoplastic Disorders of the Central Nervous System: Update on Diagnostic Criteria and TreatmentSeminars in Neurology, 2004
- Recommended diagnostic criteria for paraneoplastic neurological syndromesJournal of Neurology, Neurosurgery & Psychiatry, 2004
- Paraneoplastic neurological syndromes: an update on diagnosis, pathogenesis, and therapyThe Lancet Neurology, 2002
- Cytotoxic T cell activity against the peptide, AYRARALEL, from Yo protein of patients with the HLA A24 or B27 supertype and paraneoplastic cerebellar degenerationJournal of the Neurological Sciences, 2001
- Passive transfer and active immunization with the recombinant leucine-zipper (Yo) protein as an attempt to establish an animal model of paraneoplastic cerebellar degenerationJournal of the Neurological Sciences, 1994
- Antibodies to brain proteins in paraneoplastic cerebellar degenerationNeurology, 1986
- Partial characterization of the Purkinje cell antigens in paraneoplastic cerebellar degenerationNeurology, 1986